Background: There are scant outcomes data in patients with type 2 diabetes and stable
coronary artery disease (CAD) stratified by detailed angiographic burden of CAD or left …

Background—The clinical characteristics that identify high-risk subsets of patients with
unprotected left main coronary artery disease undergoing percutaneous coronary …

The care of patients 65 years or older presents a challenge for evidence-based medicine.
Such patients are underrepresented in clinical trials, are more vulnerable to treatment …

Previous meta‐analyses showed that coronary artery bypass grafting (CABG) has lower all‐
cause mortality than percutaneous coronary intervention (PCI) for the management of …

Patients with multivessel coronary artery disease attain important QOL benefits following
revascularization with either PCI or CABG. Percutaneous treatments lead to a more rapid …

Percutaneous coronary intervention (PCI) decreases ischemic complications of acute
coronary syndromes. The benefits of PCI in stable ischemic heart disease (SIHD) depend on …

Objectives: The authors undertook a patient-level meta-analysis to compare long-term
outcomes after coronary artery bypass grafting (CABG) versus percutaneous coronary …

This position statement addresses issues in revascularization for multivessel coronary artery
disease (CAD) from the perspective of both cardiologists and cardiac surgeons …

Coronary revascularization is the most important strategy for coronary artery disease. This
review summarizes the current most prevalent approaches for coronary revascularization …

Background and Aims Data are emerging on 10-year mortality comparing coronary artery
bypass grafting (CABG) and percutaneous coronary intervention (PCI) with stenting for …